Dynogen Pharmaceuticals
Latest round
- Series B
Last raised
- Apr 2004
Total raised
- $63M
Investors
- 8
About Dynogen Pharmaceuticals
Dynogen is a clinical-stage biopharmaceutical company developing innovative treatments for gastrointestinal and genitourinary disorders.
Who invested in Dynogen Pharmaceuticals
8 investors across 2 rounds
See all investors in Dynogen Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Dynogen Pharmaceuticals
Who invested in Dynogen Pharmaceuticals?
Dynogen Pharmaceuticals has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Dynogen Pharmaceuticals raised?
Dynogen Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Dynogen Pharmaceuticals last raise money?
Dynogen Pharmaceuticals's most recent round on record is a Series B, in Apr 2004.
What does Dynogen Pharmaceuticals do?
Dynogen is a clinical-stage biopharmaceutical company developing innovative treatments for gastrointestinal and genitourinary disorders.
Where is Dynogen Pharmaceuticals headquartered?
Dynogen Pharmaceuticals is headquartered in Waltham, US.
Which VCs invest in companies like Dynogen Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Dynogen Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Dynogen Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.